Table of Contents Author Guidelines Submit a Manuscript
Stroke Research and Treatment
Volume 2011 (2011), Article ID 534362, 9 pages
Clinical Study

Treatment Challenges in Pediatric Stroke Patients

1Department of Pediatric Neurology, School of Medicine, Ankara University, Turkey
2Department of Pediatric Neurology, Dışkapı Hematology-Oncology Hospital, Turkey
3Department of Pediatric Molecular Genetics, School of Medicine, Ankara University, Turkey
4Department of Pediatric Hematology, School of Medicine, Ankara University, Turkey

Received 15 September 2010; Accepted 18 November 2010

Academic Editor: Turgut Tatlisumak

Copyright © 2011 A. Yılmaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aim. In this study we presented our experience of 18 years on the etiology, risk factors, prophylactic and acute treatment, the effect of treatment to recurrence rate of patients with stroke. Methods. The population included 108 patients who had been treated for stroke at Pediatric Neurology Department of Ankara University with the diagnosis of arterial ischemic stroke and sinovenous thrombosis between January 1992 and August 2010. Forty-one girls (38%) and 67 boys (62%) with mean symptom age 3 . 1 ± 4 . 0 4 years, (0–18 years old) were followed up with a mean period of 4 . 9 ± 3 . 7 8 years (0–17 years). Results. 30 patients had no risk factors, 34 patients had only one risk factor and 44 patients had multiple risk factors. Recurrence was seen in three patients. There was no any statistical correlation between the recurrence of stroke and the existence of risk factors ( 𝑃 = . 9 6 1 ). Seventeen patients received prophylactic treatment; 2 of them without any risk factors, 3 had one risk factor, 12 patients, who constituted the majority of our patients, had multiple risk factors ( 𝑃 = . 0 2 4 ). Conclusion. With this study we showed that the right prophylaxis for right patients reduces the rate of recurrence.